Trafficking pathway and affectivity on extracellular signal-regulated kinase phosphorylation of anti-tumor fusion protein of epidermal growth factor-adenovirus early region 4 open reading frame 4 protein.
- VernacularTitle:靶向性抗肿瘤融合蛋白-表皮生长因子-腺病毒早期转录区4第4编码蛋白在细胞内的转运及对胞外信号调节激酶磷酸化的影响
- Author:
Cun-lin WANG
1
;
Hong CHEN
;
Xiao-li MA
;
Xin WANG
;
Bing-ren HUANG
Author Information
- Publication Type:Journal Article
- MeSH: Adenovirus E4 Proteins; pharmacokinetics; Cell Line, Tumor; Epidermal Growth Factor; pharmacokinetics; Extracellular Signal-Regulated MAP Kinases; metabolism; Humans; Phosphorylation; drug effects; Protein Transport; Recombinant Fusion Proteins; pharmacokinetics; Viral Proteins; pharmacokinetics
- From: Acta Academiae Medicinae Sinicae 2009;31(6):674-678
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the intracellular trafficking pathway of fusion protein epidermal growth factor-adenovirus early region 4 open reading frame 4 protein (EGF-E4orf4) internalized via epidermal growth factor (EGF) receptor and its affectivity on extracellular signal-regulated kinase (ERK) phosphorylation.
METHODSMDA-MB-231 and BGC823 cells were incubated with fluorescein isothiocyanate-EGF-E4orf4 or EGF at different time points. The specific molecular mark of early endosome or late lysosome was labeled by indirect immunofluorescence, and then colocalization staining was observed using confocal laser microscopy. The levels of ERK phosphorylation were detected by Western blot.
RESULTSThe fluorescent signal of fusion protein EGF-E4orf4 accumulated within the cells and congregated to the perinuclear region. A nucleus localization of the fusion protein was only at MDA-MB-231 cell. Colocalization of EGF-E4orf4 with early endosome/late lysosome was observed. EGF-E4orf4 stimulated ERK phosphorylation, which was most obvious 10 minutes after stimulation, and then gradually attenuated, which was similar to EGF stimulation but with a less decrease.
CONCLUSIONSInternalized EGF-E4orf4 can be slowly degraded via endosome-lysosome pathway. The action features of EGF-E4orf4 are remarkably different between MDA-MB-231 and BGC823 cells, which may help explain the differences in its anti-tumor potency and in the special selectivity toward different tumor cells.